Coulter & Justus Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,600
Closed -$461K 94
2023
Q4
$461K Hold
1,600
0.31% 23
2023
Q3
$430K Hold
1,600
0.31% 27
2023
Q2
$355K Hold
1,600
0.24% 30
2023
Q1
$387K Hold
1,600
0.25% 33
2022
Q4
$420K Hold
1,600
0.29% 33
2022
Q3
$361K Hold
1,600
0.28% 30
2022
Q2
$389K Buy
+1,600
New +$392K 0.31% 29
2022
Q1
Sell
-1,600
Closed -$360K 14
2021
Q4
$360K Buy
+1,600
New +$338K 0.28% 36

Other funds holding AMGN

Coulter & Justus Financial Services's AMGN Position: Q1 2024 in Review

Coulter & Justus Financial Services sold out of Amgen (AMGN) in Q1 2024, closing a stake of 1,600 shares — an estimated $461K sold.

Coulter & Justus Financial Services first reported a position in AMGN in Q4 2021 and held it in 8 quarters. The position peaked at $461K in Q4 2023. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Coulter & Justus Financial Services reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Coulter & Justus Financial Services sold 1,600 Amgen shares in Q1 2024, an estimated $461K.
  • Coulter & Justus Financial Services first reported a position in Amgen in Q4 2021 and held it in 8 quarters.
  • Coulter & Justus Financial Services's Amgen position peaked at $461K in Q4 2023.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Coulter & Justus Financial Services's 13F filing for Q1 2024, filed 3 May 2024.